During the past decade, Hoag Cancer Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hoag Cancer Center" are "Melanoma" (1 trials), "Merkel Cell Carcinoma, Unspecified" (1 trials), "Non Small Cell Lung Cancer" (1 trials), "Non-muscle Invasive Bladder Cancer" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Hoag Cancer Center" in a lesser frequency.

Most popular intervention types in "Hoag Cancer Center" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "BCG" (1 trials), "BCG+N-803" (1 trials) and "zirconium Zr 89 crefmirlimab berdoxam" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hoag Cancer Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hoag Cancer Center". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hoag Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hoag Cancer Center, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".